Preserved GLP-I effects on glycogen synthase α activity and glucose metabolism in isolated hepatocytes and skeletal muscle from diabetic rats

Diabetes

Volumn 46, Issue 8, 1997, Pages 1264-1269

  Morales, Mónica ^a   López Delgado, María I ^a   Alcántara, Ana ^a   Luque, Miguel A ^a   Clemente, Felipe ^a   Márquez, Luis ^a   Puente, Jesús ^a   Viñambres, Concepción ^a   Malaisse, Willy J ^b   Villanueva Peñacarrillo, María L ^a   Valverde, Isabel ^a,c  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c Department Metabolismo ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; GLYCOGEN SYNTHASE; INSULIN; LACTIC ACID; STREPTOZOCIN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE METABOLISM; GLYCOGEN SYNTHESIS; INSULIN DEPENDENT DIABETES MELLITUS; LIVER CELL; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; STREPTOZOCIN DIABETES;

EID: 1842329143     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.8.1264     Document Type: Article

References (43)

1. Gutniak M, Orskov C, Holst JJ, Ahrén B, Effendic S: Antidiabetogenic effects of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326:1316-1322, 1992
2. D'Alessio DA, Kahn SE, Leusner CR, Ensinck JW: Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposai J Clin Invest 93:2263-2266, 1994
3. D'Alessio DA, Prigeon RL, Ensinck JW: Enterai enhancement of glucose disposition by both insulin-dependent and insulin-independent processes: a physiologic role of glucagon-like peptide 1. Diabetes 44:1433-1437, 1995
4. Toft-Nielsen MB, Madsbad S, Holst JJ: The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones. Diabetes 45:552-556, 1996
5. Orskov L, Holst JJ, Moller N, Orskov C, Alberti KGMM, Schmitz O: GLP-1 does not acutely affect insulin sensitivity in healthy man. Diabetologia 39:1227-1232, 1996
6. Oben J, Morgan L, Fletcher J, Marks V: Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(736)amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130:267-272, 1991
7. Egan JM, Montrose-Rafizadeh C, Wang YH, Bernier M, Rothet J: Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action. Endocrinology 135:2070-2075, 1994
8. Miki H, Namba M, Nishimura T, Mineo I, Matsumura T, Miyagawa J, Nakajima H, Kuwajima M, Hanafusa T, Matsuzawa Y: Glucagon-like peptide-1(736)amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes. Biochim Biophys Acta 1312:132-136, 1996
9. Perea A, Viñambres C, Clemente F, Villanueva-Peñacarrillo ML, Valverde I: GLP-1(7-36)amide effects on glucose transport and metabolism in adipose tissue. Horm Metab Res. In press
10. Wang Y, Kole H, Egan JM: Regulation of glucose transporters in 3T3-L1 adipocytes: effects of GLP-1 and insulin. Diabetes 45 (Suppl. 2):301A, 1996
11. 2 in rat skeletal muscle. Diabetotogia 37:1163-1166, 1994
12. Montrose-Rafizadeh CH, Egan JM, Moyes CD, Taha C, Wang Y, Klip, A, Roth J: Extrapancreatic effects of GLP-1 in an insulin-sensitive muscle cell line (L6) (Abstract). Diabetes 44 (Suppl. 1):234A, 1995
13. Yano H, Egan JM, Wang Y, Taha C, Moyes C, Klip A, Montrose-Rafizadeh C: Muscle and pancreas express distinct GLP-1 receptors. (Abstract). ICE'96 P1-888, 1996
14. O'Harte FPM, Gray AM, Abdel-Wahab YHA, Flatt PR: Effects of glycated and non-glycated GLP-1[7-36]amide on glucose metabolism in muscle (Abstract). Diabetologia 39 (Suppl. 1):A23, 1996
15. Valverde I, Morales M, Clemente F, López-Delgado MI, Delgado E, Perea A, Villanueva-Peñacarrillo ML: Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett 349:313-316, 1994
16. Villanueva-Peñacarrillo ML, Delgado E, Trapote MA, Alcántara A, Clemente F, Luque MA, Perea A, Valverde I: Glucagon-like peptide-1 binding to rat hepatic membranes. J Endocrinol 146:183-189, 1995
17. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE: Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133:57-62, 1993
18. Campos RV, Lee YC, Drucker DJ: Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134:2156-2164, 1994
19. Delgado E, Luque MA, Alcántara A, Trapote MA, Clemente F, Galera C, Valverde I, Villanueva-Peñacarrillo ML: Glucagon-like peptide-1 receptors in rat skeletal muscle. Peptides 16:225-229, 1995
20. Mérida E, Delgado E, Molina LM, Villanueva-Peñacarrillo ML, Valverde I: Presence of glucagon and glucagon-like peptide 1(7-36)amide receptors in solubilized membranes of human adipose tissue. J Clin Endocrinol Metab 77:1654-1657, 1993
21. Valverde I, Mérida E, Delgado E, Trapote MA, Villanueva-Peñacarrillo ML: Presence and characterization of glucagon-like peptide 1(7-36)amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132:75-79, 1993
22. Thorens B: Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645, 1992
23. Galera C, Clemente F, Alcántara AI, Trapote MA, Perea A, López-Delgado MI, Villanueva-Penacarrillo ML, Valverde I: Inositolphosphoglycans and diacylglycerol are possible mediators in the glycogenic effect of GLP-1 (7-36)amide in BC3H-1 myocytes. Cell Biochem Funct 14:43-48, 1996
24. Trapote MA, Clemente F, Galera C, Morales M, Alcántara AI, López-Delgado MI, Villanueva-Peñacarrillo ML, Valverde I: Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7-36)amide action in the liver. J Endocrinol Invest 19:114-118, 1996
25. Villanueva-Peñacarrillo ML, Mérida E, Delgado E, Molina ML, Arrieta F, Rovira A, Valverde I: Increased glucagon-like peptide-1 (7-36)amide binding in adipose tissue from non-insulin dependent and insulin-dependent diabetic patiente. Diab Nutr Metab 7:143-148, 1994
26. Villanueva-Peñacarrillo ML, Delgado E, Vicent D, Mérida E, Alcántara AI, Valverde I: GLP-1(7-36)amide binding in skeletal muscle membranes from streptozotocin diabetic rate. Endocrine 3:685-687, 1996
27. Valverde I, Delgado E, Mérida E, Vicent D, Trapote MA, Alcántara AI, Villanueva-Peñacarrillo ML: GLP-1(7-36)amide binding in liver membranes from streptozotocin diabetic rats. Diab Nutr Metab 9:103-105, 1996
28. Hirota M, Hashimoto M, Hiratsuka M, Ohboshi C, Yoshimoto C, Yano M, Mizuno A, Shima K: Alterations of plasma immunoreactive glucagon-like peptide-1 behavior in non-insulin-dependent diabetics. Diabetes Res Clin Pract 9:179-185, 1990
29. Orskov C, Jeppesen J, Madsbad S, Holst JJ: Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415-423, 1991
30. Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M, Sasaki H: Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet Med 10:44-49, 1993
31. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt WJ: Preserved incretin activity of glucagon-like peptide-1(7-36)amide but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91:301-307, 1993
32. Portha B, Picon L, Rosselin G: Chemical diabetes in the adult rat as the spontaneous evolution of neonatal diabetes. Diabetologia 17:371-377, 1979
33. Hue L, Bontemps F, Hers HG: The effect of glucose and of potassium ions on the interconversion of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparation. Biochem J 152:105-114, 1975
34. Le Marchand-Brustel YM, Freychet P: Regulation of glycogen synthase activity in the isolated mouse soleus muscle: effect of insulin, epinephrine, glucose and anti-insulin receptor antibodies. Biochim Biophys Acta 677:13-22, 1981
35. Crettaz M, Prentki M, Zaninetti D, Jeanrenaud B: Insulin resistance in soleus muscle from obese Zucker rats. Biochem J 186:525-534, 1980
36. Fleig WE, Noether-Fleig G, Fussgaenger R, Ditschuneit H: Modulation by a sulfonylurea of insulin-dependent glycogenesis, but not of insulin binding, in cultured rat hepatocytes. Diabetes 33:285-290, 1984
37. Cuendet GS, Ernest G, Loten BJ, Renold A: Decreased basal, noninsulinstimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice. J Clin Invest 58:1078-1088, 1976
38. Camara J, Galera C, Valverde I, Malaisse WJ: Relationship between D-glucose oxidation and glycolysis in tumoral pancreatic islet cells with either rapid or decreased cell growth. Diabetes 17:67-71, 1991
39. Hohorst H-J: L(+)lactate determination with lactic dehydrogenase and DPN. In Methods of Enzymatic Analysis, Bergmeyer HU, Ed. San Diego, Academic, 1965, p. 266-270
40. Fürnsinn C, Ebner K, Waldbäusl W: Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle. Diabetologia 38:864-867, 1995
41. Nakagawa Y, Kawai K, Suzuki H, Ohashi S, Yamashita K: Glucagon-like peptide-1(7-36) amide and glycogen synthesis in the liver (Letter). Diabetologia 39:1241, 1996
42. Leclercq-Meyer V, Malaisse WJ: Potentation of GLP-1 insulinotropic action by a nonglucidic nutrient in the pancreas of diabetic GK rats. Biochem Mol Med 59:87-90, 1996
43. Ahrén Bo, Larsson H, Heiber S, Juneskans O, Holst JJ, Gutniak MK: GLIP (GLP-1(7-36)amide) tablet lowers blood glucose in humans (Abstract). Diabetes 45 (Suppl 2):28A, 1996